In addition to very high NfL levels seen in CJD, the rapidly progressive disease exhibits unique, multi-fold increase in concentration of multiple other CSF biomarkers, including total tau, alpha-synuclein and neurogranin [52–54]. This evidence concerns the gene NEFL and Creutzfeldt Jacob disease.